ClinicalTrials.Veeva

Menu

Noninvasive Physiologic Sensors to Assess Depression

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Major Depressive Disorder
Depression

Treatments

Other: Physiological Sensors
Other: Sleep Monitoring Device
Other: Vocal Monitoring
Other: Mobile Phone

Study type

Observational

Funder types

Other

Identifiers

NCT02568865
2015P001913

Details and patient eligibility

About

This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients with Depression (n=40):

  1. Adults (ages 18-75),
  2. Able to read, understand, and provide written informed consent in English,
  3. Meet criteria for a primary psychiatric diagnosis of major depressive disorder for ≥ 4 weeks, according to the M.I.N.I (Mini International Neuropsychiatric Interview),
  4. Hamilton Depression Rating Scale (HDRS) total score ≥ 18,
  5. Engaged in or willing to be referred for clinical care for depression treatment as usual (antidepressants and/or psychotherapy),
  6. Must have measurable skin conductance/electrodermal activity (as assessed at the screening visit),
  7. Must own a working Android smartphone (Android 2.3+) and use it regularly,
  8. Must own a windows PC (or tablet) or a Mac computer (or laptop),
  9. Must have access to Internet service every day.

Healthy Controls (n=10):

  1. Adults (ages 18-75),
  2. Able to read, understand, and provide written informed consent in English,
  3. Not meet criteria for past or current psychiatric illness, excluding specific phobias, as measured by the M.I.N.I.,
  4. Not have a first-degree relative with known major psychiatric illness including Major Depressive Disorder, Bipolar Disorder, Psychotic Disorder or Substance Use Disorder,
  5. Must have measurable skin conductance/electrodermal activity (as assessed at the screening visit),
  6. Must own a working Android smartphone (Android 2.3+) and use it regularly,
  7. Must own a windows PC (or tablet) or a Mac computer (or laptop),
  8. Must have access to Internet service every day.

Exclusion Criteria (for all subjects):

  1. Active drug or alcohol use disorder in the past 3 months,
  2. History of psychosis,
  3. History of mania or hypomania,
  4. Epilepsy or history of seizures,
  5. Untreated hypothyroidism,
  6. Unstable medical disease,
  7. Cognitive impairment that would impede adherence to study procedures,
  8. Acute suicide or homicide risk,
  9. Current treatment with electroconvulsive therapy, vagal nerve stimulation therapy, deep brain stimulation, transcranial magnetic stimulation therapy, or phototherapy,
  10. Concurrent participation in other research studies,
  11. Cannot comprehend or communicate in English,
  12. Lack of working smartphone or lack of daily access to Internet service,
  13. Inability to measure skin conductance/electrodermal activity (as assessed at the screening visit), and
  14. Inability or unwilling to, at minimum, wear the physiological sensor (E4) bands, fill out the surveys, and record a weekly diary.

Trial design

50 participants in 2 patient groups

Major Depressive Disorder
Treatment:
Other: Mobile Phone
Other: Physiological Sensors
Other: Vocal Monitoring
Other: Sleep Monitoring Device
Healthy Volunteers
Treatment:
Other: Mobile Phone
Other: Physiological Sensors
Other: Vocal Monitoring
Other: Sleep Monitoring Device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems